6 unchanged sentences
3.3 Bylaws of Ginkgo Bioworks Holdings, Inc.
−Removed: (incorporated by reference to Exhibit 3.
−Removed: 1 of the Company's Current Report on Form 8-K filed with the SEC on October 27, 2023).
+Added: (incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K filed with the SEC on October 27, 2023).
+Added: 10.1* Form of Stock Option Agreement for 2024 Founder Award Program, granted under the Ginkgo Bioworks Holdings, Inc.
+Added: 2021 Incentive Award Plan .
31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
Ginkgo Bioworks Holdings, Inc.
−Removed: November 8, 2023
/s/ Jason Kelly
Chief Executive Officer (Principal Executive Officer)
−Removed: November 8, 2023
/s/ Mark Dmytruk
Chief Financial Officer (Principal Financial Officer)
−Removed: November 8, 2023
−Removed: /s/ Steven P.
+Added: /s/ Steven Coen
Chief Accounting Officer (Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.